Welcome to the Department of Radiation Oncology

Message from James M. Metz, MD — Chairman

Penn Radiation Oncology is dedicated to a three-part mission of excellence in patient care, basic and translational research, and the education of residents and students. We are committed to delivering excellence in every area and as such we steadfastly believe that "Excellence is Standard."

Penn Radiation Oncology is one of the most comprehensive radiation oncology programs in the world. The outstanding faculty and staff, combined with Penn’s extensive collection of advanced technology, gives patients access to nearly every treatment option available for their cancer. The broad range of radiation treatments available include proton therapy, intensity-modulated radiation therapy (IMRT), high-dose rate (HDR) and low-dose rate brachytherapy, partial breast irradiation, stereotactic radiosurgery (SRS), and Gamma Knife radiation. With the Abramson Cancer Center of the University of Pennsylvania, Penn Radiation Oncology provides patient care at the Ruth and Raymond Perelman Center for Advanced Medicine and seven community-based sites.

Read more of the Message from the Chair »

News

  • Dose-Escalated Radiation Therapy for High-Risk Localized Prostate Cancer Friday, February 9, 2024

    For patients with high-risk prostate cancer, treatment with long-term androgen deprivation therapy (ADT) and high-dose radiation was associated with significantly better survival compared with ADT and standard-dose radiation. Neha Vapiwala, MD, a professor of Radiation Oncology, who was not involved in the study, commented on the results during the 2024 American Society for Clinical Oncology Genitourinary Cancers Symposium.

    ASCO Post

  • Higher-Dose Radiation Therapy Extends Survival in High-Risk Prostate Cancer Monday, January 29, 2024

    For patients with high-risk prostate cancer, treatment with long-term androgen deprivation therapy (ADT) and high-dose radiation was associated with significantly better survival compared with ADT and standard-dose radiation. Neha Vapiwala, MD, a professor of Radiation Oncology, who was not involved in the study, commented on the results during the 2024 American Society for Clinical Oncology Genitourinary Cancers Symposium.

  • The Importance of Collaboration between Academic Medicine and Community Oncology Practices Wednesday, January 3, 2024

    Justin Bekelman, MD, a professor of Radiation Oncology and director of the Penn Center for Cancer Care Innovation, joins the “Oncology Onward” podcast to discuss the importance of collaboration between academic medicine and community oncology, and testing innovative cancer care delivery in these settings.

    AJMC

More News

Upcoming Events

    More Events



    Penn Medicine Radiation Oncology Instagram